Tianhua Xu

机构：China Tobacco, Tobacco Research Institute, Shenyang Sujiatun District Central Hospital, Jiangsu Province Hospital, Hebei Normal University of Science and Technology, Nanjing Medical University · ORCID：0000-0002-7093-5325

发表论文 41 篇 · 总被引 608 次 · h-index 16

代表论文

• The RAISE Trial: A Novel Device and First-in-Man Trial (2022 · Circulation Heart Failure · 被引 29)
• Low‑intensity pulsed ultrasound promotes apoptosis and inhibits angiogenesis via p38 signaling‑mediated endoplasmic reticulum stress in human endothelial cells (2019 · Molecular Medicine Reports · 被引 29)
• Low-intensity pulsed ultrasound ameliorates angiotensin II-induced cardiac fibrosis by alleviating inflammation via a caveolin-1-dependent pathway (2021 · Journal of Zhejiang University SCIENCE B · 被引 27)
• Low‐intensity pulsed ultrasound prevents prolonged hypoxia‐induced cardiac fibrosis through HIF‐1α/DNMT3a pathway via a TRAAK‐dependent manner (2021 · Clinical and Experimental Pharmacology and Physiology · 被引 25)
• Alamandine alleviated heart failure and fibrosis in myocardial infarction mice (2022 · Biology Direct · 被引 20)
• Esculin targets TLR4 to protect against LPS-induced septic cardiomyopathy (2024 · International Immunopharmacology · 被引 19)